NCT02324088View on ClinicalTrials.gov

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2015

Conditions
Inflammatory Breast Cancer
Interventions
DRUG

Docetaxel

DRUG

Cyclophosphamide

DRUG

Epirubicin

All Listed Sponsors
lead

UNICANCER

OTHER

NCT02324088 - Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer | Biotech Hunter | Biotech Hunter